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h i g h l i g h t s
Manganese metallodrugs are highly stable, usually redox-active pharmaceuticals.
 Stable, redox-active EUK108 was the most lethal metallodrug.
 Dorsal telencephalic nucleus of the ﬁsh brain was unaffected after Mn treatment.a r t i c l e i n f o
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Manganese is an essential metal which can be neurotoxic in some instances. As Mn-based metallodrugs
are ever more prevalent in clinical practice, concern regarding the toxic effects of Mn discharges to water
bodies on the biota prompted us to study the physicochemical parameters of these complexes and to
assess their acute toxicity toward adult Danio rerio individuals, particularly in terms of brain tissue dam-
age. Our results show that the Mn(III)-salen acetate complex EUK108 is toxic, which can be rationalized
in terms of its lipophilicity, stability and redox activity.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Manganese (Mn) is a constitutive element of a series of impor-
tant enzymes and cofactors fundamental for brain function, such as
glutamine synthetase, superoxide dismutase and others (Yokel,
2009). In these biological systems, the choice of the metal ion is
dependent on its ability to catalyze speciﬁc redox reactions, in a
way similar to that of other metalloprotein systems based on trace
metals such as iron or copper. Mn acquired from the diet, drinking
water or as inhaled particles may be assimilated and delivered to
the brain via active transport through the blood–brain barrier,
olfactory nerve or cerebrospinal ﬂuid (Yokel, 2009).
Being highly reactive, it has been claimed that dysfunctions in
the metabolism of redox-active trace metals could be at the origin
of several neurological disorders such as Alzheimer’s or Parkinson’s
Disease and Amyotrophic Lateral Sclerosis (Bush, 2000; Lucchini
et al., 2009). Indeed, manganese overload, linked to the absence
of other antioxidant cations, has been associated with the onset
of localized outbreaks of transmissible spongiform encephalopathy
(‘‘mad cow disease’’) (Purdey, 2000). In the human version of thiscondition, Creutzfeldt–Jakob Disease, imbalances between copper
and manganese levels in the brain have been reported, where ex-
cess Mn could compete for the copper binding site of the antioxi-
dant prion protein leading to loss of function and deleterious
effects on the central nervous system (for a review, see Singh
et al. (2010)). Also, workers exposed to Mn (miners, welders and
users of Mn-based fungicides such as Maneb™ and Mancozeb™)
have shown increased symptoms of a Parkinson-like neurological
dysfunction termed manganism (Aschner et al., 2009; Yokel,
2009). Therefore, there is an important debate underway regarding
the need to revise the commonly-accepted levels of Mn exposure
(0.4 mg L1 in drinking water (WHO, 2008)) after several reports
of neurotoxic effects in chronically-exposed populations (Ljung
and Vahter, 2007; Lucchini and Zimmerman, 2009; Menezes
et al., 2009a,b; Santamaria and Sulsky, 2010).
Fish toxicity of manganese compounds has only been described
for Mn(II) salts. The deleterious effects of either chronic or acute
exposure to manganese depend on species and, within a species,
depend on the tissue. A common investigative target is the antiox-
idant system of the organism, which seems particularly prone to
the disruptive effects of manganese. For example, decreased activ-
ities of catalase have been observed in the brains of Colossoma
macropomum (Gabriel et al., 2013) and Rhamdia quelen (Dolci
et al., 2013); inhibition of brain superoxide dismutase was
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auratus (Vieira et al., 2012). Other biomarkers of oxidative stress
such as lipid peroxidation, glutathione levels and glutathione per-
oxidase activity were enhanced in these species. Interestingly, R.
quelen grown with manganese under hypoxic conditions was less
sensitive to lipid peroxidation and other oxidative markers (Dolci
et al., 2013), which support the (at least partial) involvement of
molecular oxygen and/or reactive oxygen species in the toxicity
of manganese species. In addition, manganese has been linked to
the depletion of liver glycogen in ﬁsh (Colisa fasciatus (Nath and
Kumar, 1987)), simulating a physical exertion which, along with
the oxidative stress, shall debilitate the animal.
Manganese-based metallodrugs such as Mn(III)-bis(salicylalde-
hyde)ethylenediamine (salen) derivatives and Mn(III) desferriox-
amine have been suggested as possible mimetics of enzymes in
antioxidant therapy since they can mimic the effects of superoxide
dismutase and catalase, although via a non-speciﬁc pathway (Hahn
et al., 1991; Faulkner et al., 1994; Day, 2009). Also, Mn derivatives
are commonly used as contrast agents in magnetic resonance
images (Freeland-Graves et al., 2005). Given the concern regarding
the persistence of pharmaceuticals in water bodies (Christen et al.,
2010), the fact that metallodrugs are quintessentially poorly
degradable (as far as the metal center is concerned) and the wide-
spread usage of Mn metallodrugs, the toxic effects of trace Mn-
based drugs discharged into water systems toward both humans
and wildlife have been long overlooked.
In this study, we assessed the acute toxicity of Mn(III)-salen
acetate (EUK108), Mn(III)-desferrioxamine (Mn(dfb)) and Mn(III)-
acetohydroxamate (Mn(aha)) toward adult Danio rerio ﬁshes, par-
ticularly in terms of brain damage, and its correlation with the
complex stability, lipophilicity and ability to promote peroxide-
mediated oxidative damage in organic molecules of these com-
pounds. It was found that the stable, highly redox-active and rela-
tively lipophilic compound EUK108 was the most active.Table 1
Octanol–water partition coefﬁcients (P). Concentration values (c) are expressed in
lmol Mn L1 as an average ± sd of three determinations.
cwater coctanol P Log P
Mn(dfb) 178 ± 0.911 3.28 ± 2.37 0.0184 ± 0.0068 1.73
Mn(aha) 357 ± 1.82 39.5 ± 4.19 0.111 ± 0.021 0.95
EUK108 255 ± 1.82 19.1 ± 6.38 0.0749 ± 0.027 1.132. Materials and methods
2.1. Chemicals
Mn(dfb) and Mn(aha): the complex manganese(III)-desferriox-
amine was prepared by a procedure already described (Faulkner
et al., 1994). Equimolar amounts of desferrioxamine mesylate
and MnCl2 were mixed in deionized water and the pH was adjusted
to 9 with the addition of NaOH. The solution was stirred under air
for 2 h. The solution turned slowly from colorless to green, which
indicated the formation of the complex Mn(dfb). The new complex
Mn(aha) was prepared in a similar way, with the only difference
being that the stoichiometric proportion of acetohydroxamic
acid:MnCl2 was 3:1. After the reaction, the solution turned deep
red.
EUK108: this complex was prepared by previously described
protocols (Boucher, 1974). Initially, the ligand salen was produced
by the slow addition of two equivalents of salicylic aldehyde to one
equivalent of ethylenediamine in methanolic solution. The ligand
salen was obtained as a yellow precipitate. Manganese(II) acetate
and salen were mixed in 95% ethanol at a molar ratio of 1:2 and re-
acted under reﬂux for 3 h. After removing the solvent, the residue
was extracted with distilled water at 60 C and ﬁltered. To the ﬁl-
trate it was added excess of potassium acetate, which leads to the
immediate precipitation of the complex as a brown powder. This
was dried and recrystallized with acetone-diethyl ether.
Stock solutions of 10 mM of each complex were prepared in
deionized water and used to prepare the other solutions used in
this study. The concentrations (in a Mn base) of the stock solutions
were determined by means of inductively coupled plasma opticalemission spectrometry (ICP-OES). All the complexes are stable
within the timeframe of the experiment with animals (96 h).
2.2. Physicochemical determinations
Octanol–water partition coefﬁcients were determined at room
temperature by the shake-ﬂask method (Dearden and Bresnen,
1988). The relative stability of the complexes was studied by the
quenching of the ﬂuorescent probe calcein as a model of high-
afﬁnity biological binding sites (Esposito et al., 2002c). Pro-oxidant
activity mediated by peroxide was assessed ﬂuorimetrically by the
dihydrorhodamine (DHR) oxidation method (Esposito et al., 2002b,
2003; Do Amaral and Esposito, 2008).
2.3. Animal studies
Acute toxicity tests were performed according to the OECD
guidelines (OECD, 1992). Adult zebraﬁsh (D. rerio; n = 10) were
kept in 40-L ponds with twice-a-day feeding and a 12-h photope-
riod in the presence of the complexes. The pH (7.2 ± 0.6), temper-
ature (25 ± 2 C), behavior and death were registered at each
sampling time. After 96 h, animals exposed to Mn(dfb) 1000 lM
(the less toxic compound) or EUK108 20 lM (the more toxic com-
pound) were sacriﬁced and their brains were removed by surgery,
immediately ﬁxed in Bouin’s ﬁxative and embedded in parafﬁn.
Histological slices were stained with hematoxylin-eosin (HE) and
analysis of the dorsal nucleus of the ventral telencephalon (Vd)
area, which corresponds to the human basal ganglia (Rink and
Wullimann, 2004; Wullimann and Mueller, 2004) where Mn is
preferentially accumulated (Roth, 2009), was performed.3. Results and discussion
3.1. Lipophilicity and relative stability
All of the complexes tested are neutral and highly hydrophilic
(Table 1), but EUK108 is around four times more lipophilic than
Mn(dfb), which may be of relevance for crossing biological mem-
branes (e.g., gills). Mn(aha) was the most lipophilic complex,
although the least stable one when challenged with the ﬂuorescent
chelator calcein (Fig. 1). Calcein ﬂuorescence is quenched by sev-
eral metal ions upon coordination to its chelator moiety (Esposito
et al., 2002a). The metal complexes which have high quenching
ability are those where the metal is less tightly bound to the li-
gands, and thus this assay rapidly provides biologically relevant
information on their relative thermodynamic stability (highest
quenching meaning lowest stability). The fact that Mn(aha) and,
to a lesser extent, Mn(dfb) induced measurable quenching, indi-
cates that both complexes are unlikely to remain intact upon con-
frontation with high-afﬁnity biological chelators. EUK108, on the
other hand, might survive these challenges and remain relatively
unchanged.
3.2. Pro-oxidant activity of the complexes
In order to further assess the possible impact of the Mn com-
plexes, the rate of oxidation of the ﬂuorescent probe DHR as a
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Fig. 1. Quenching of calcein ﬂuorescence induced by the Mn metallodrugs.
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od has been proposed as a means to quantify oxidative-based bio-
logical injury stemming from redox-active metal overload
(Esposito et al., 2003). Besides being catalase/SOD mimetics,
Mn(III) complexes have been found to form highly oxidant species
upon reaction with peroxide (Do Amaral and Esposito, 2008). In
this study, Mn(aha) did not display any pro-oxidant activity. Like
its chloride counterpart EUK8 (Do Amaral and Esposito, 2008),
EUK108 induced oxidative stress even at very low (<5 lM) perox-
ide levels, which are close to physiologically relevant H2O2 levels
(Day, 2009).
It was recently found that Mnmetallodrugs may behave as pro -
oxidants under certain conditions of the depletion of natural anti-
oxidants (glutathione, ascorbate) and increased peroxide concen-
trations (Do Amaral and Esposito, 2008). One of the underlying
reasons for this concern is the fact that low molecular weight
Mn(III) complexes are strong oxidants of biological polymers per
se (Jiang et al., 2007). In fact, Mn(III)-pyrophosphate has been
found to induce dopamine oxidation in PC12 cells (Reaney and
Smith, 2005). Also, highly oxidant Mn(V) species may be formed
during the catalytic cycle of the complex (Leeladee and Goldberg,
2010). This is not an issue in terms of the enzyme, where the metal
center is well embedded in the amino acid skeleton, but may be an
issue when various substrates have relatively free access to the
metal. Curiously, Mn(dfb) pro-oxidant activity is high even in the0 20 40 60 80
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Fig. 2. Pro-oxidant activity of Mn complexes (10 lM) as a function of H2O2.absence of peroxide, indicating that other oxidation mechanisms
may be operative.3.3. Toxicity toward zebraﬁsh
The toxicity of trivalent Mn-derived metallodrugs towards D.
rerio has never been studied. We submitted the animals to three
Mn(III) complexes in varying concentrations to determine their
acute toxicities (Fig. 3).
Lethality in ﬁsh induced by Mn compounds varies widely with
animal species and age, manganese speciation and water chemis-
try conditions. LD50 values for divalent Mn as chloride or sulfate
salts span from ca. 40 lM to 60 mM (for Oncorhynchus kisutch
and Heteropneustes fossilis, respectively). Also, in hard water (with
high calcium content) Mn(II) toxicity toward ﬁshes decreases
(Howe et al., 2004; Peters et al., 2011), suggesting that similar
transport pathways for both elements exist (Yokel, 2009). Recently,
a biotic ligand model for divalent Mn with three different aquatic
organisms has been developed, with good correlation to experi-
mental data (Peters et al., 2011). However, data on ﬁsh toxicity
for trivalent Mn derivatives are scarce. The only study previous
to ours indicates that the citrate derivative of Mn(III) is consider-
ably less toxic to embryos of D. rerio if compared to Mn(II) citrate.
However, the combination of both species (Mn(II)/Mn(III)) had a
synergic effect on toxicity (Hernandez, 2009). In the case of mam-
mal cell models, the toxicity of Mn is also dependent upon the me-
tal oxidation state (Hernandez et al., 2011). In this study, the
toxicity of Mn(III) compounds toward D. rerio was investigated
for the ﬁrst time. EUK108 has an LC50 (lethal concentration for
50% of the population) value below the range mentioned above
(LC50 estimated as 20 lM; Fig. 3), but the hydroxamate deriva-
tives are comparatively much less toxic. Of the compounds studied
here, only the stable, relatively lipophilic and redox-active EUK108
induced death of D. rerio at low concentrations. Mn(dfb), being a
less stable, relatively large molecule of poor lipophilicity, was
hypothesized to be better tolerated by animals, which was con-
ﬁrmed in the acute toxicity tests (Fig. 3).
The antioxidant defenses are a major target of manganese(II)
overload in ﬁshes (Vieira et al., 2012; Dolci et al., 2013; Gabriel
et al., 2013), and gills, kidney, brain and liver are target organs.
Normoxic water can aggravate at least part of these effects, which
indicates a possible interplay between Mn(II) and molecular oxy-
gen where the metal is oxidized and reconverted to the divalent0 20 40 60 80 100
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Fig. 3. Acute toxicity test using Danio rerio. Fishes (n = 10) were exposed to
different concentrations of Mn(III) complexes. j = 0 lM; = 20 lM; N = 200 lM;
. = 1000 lM for Mn(dfb) and EUK108, 520 lM for Mn(aha).
Fig. 4. Ventral telencephalic (Vd) region of Danio rerio brain after different treatments. Animals from the control group (a) or exposed to Mn(dfb) 1000 lM (b) or EUK108
20 lM (c) were sacriﬁced and the slices were obtained as described in Section 2.
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generating redox-active species when in this cycle, in a way similar
to the described for mammalian cells (Pereira et al., 2013). How-
ever, in those studies in ﬁsh, very high concentrations of manga-
nese(II) (70–100 lM) were used, which are at least 10 times
higher than the dose assumed safe in drinking water (0.4 mg L1
or 7.3 lM (WHO, 2008)). But it should be kept in mind that these
data cannot be extrapolated to the stable, redox and pharmacolog-
ically active Mn(III) derivatives studied here. While their effects on
the biomarkers of oxidative stress are not known, their wastes
should be considered as a major environmental hazard.
Inspection of the dorsal telencephalic nucleus (Vd) region of
animals from the control group or treated with Mn(dfb) 1000 lM
(the less toxic compound) or EUK108 20 lM (the more toxic com-
pound) did not reveal signiﬁcant morphological changes (Fig. 4),
indicating that neurological damage, if present, was either insufﬁ-
cient to induce morphological changes, or occurred elsewhere in
the brain. This observation suggests, through the extrapolation of
D. rerio-derived neurologic damage after Mn exposure to humans,
that any adverse effect on humans would not be direct.
In general, morphological alterations in brain ﬁsh have been ob-
served only for Mn(II) treatments involving high concentrations
that lack environmental signiﬁcance, such as 4 mM MnCl2 for
96 h (Lates calcarifer; (Krishnani et al., 2003)) or 37 mM MnCl2
for 8 d (Oreochromis niloticus; (Herrera and Catap, 1992)). The
occurrence of brain toxicity after Mn(III) exposure in D. rerio clearly
requires further investigation.
Although Mn mimics of antioxidant enzymes display neuropro-
tective effects in some in vitro or in vivo animal models (Baker
et al., 1998; Pong et al., 2002; Fonck and Baudry, 2003), their lack
of speciﬁcity in biological medium (Day, 2009) as well as the re-
sults reported herein should be taken into account when consider-
ing the possible noxious effects of redox-active Mn metallodrugs
discharged to water bodies. The stability in aqueous media, the
ability to cross through biological membranes (such as gills) and
the pro-oxidant activity together represent important factors to
be considered.
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